Bancroft Fund Limited (NYSEAMERICAN:BCV – Get Free Report) Director Anthonie Vanekris sold 1,150 shares of the company’s stock in a transaction that occurred on Thursday, October 16th. The shares were sold at an average price of $23.53, for a total transaction of $27,059.50. Following the completion of the transaction, the director owned 500 shares in the company, valued at approximately $11,765. This represents a 69.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Bancroft Fund Trading Down 1.0%
Bancroft Fund stock opened at $26.46 on Friday. The firm’s 50 day moving average price is $24.16 and its two-hundred day moving average price is $23.20. Bancroft Fund Limited has a twelve month low of $18.11 and a twelve month high of $27.33.
Bancroft Fund Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th will be paid a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 5.3%. The ex-dividend date is Monday, June 15th.
Institutional Inflows and Outflows
Bancroft Fund Company Profile
Bancroft Fund, Inc (NYSE American: BCV) is a closed-end management investment company that seeks long-term growth of capital. Shares of the Fund trade on the NYSE American exchange, providing investors with access to a diversified portfolio of U.S. equity securities under a closed-end structure. The Fund’s board of directors oversees a disciplined investment process governed by a stated strategy and risk parameters.
The Fund’s primary investment objective is capital appreciation. To pursue this goal, Bancroft Fund allocates at least 80% of its total assets to equity securities of U.S.
See Also
- Five stocks we like better than Bancroft Fund
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Bancroft Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bancroft Fund and related companies with MarketBeat.com's FREE daily email newsletter.
